"We are devoted to researching causes and treatments for a variety of conditions, diseases, and ailments in multiple specialties. At Revive Research Institute, Inc., our team of board-certified physicians and highly trained research staff have a proven track record of successfully conducting full-service research studies involving medicines, vaccines, and devices. Learn more about our capabilities to provide you with the best service or contact us today for more information regarding any of our ongoing research programs."

During the past decade, Revive Research Institute conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Revive Research Institute" #1 sponsor was "Pfizer" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Veru Inc." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Revive Research Institute" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Kyowa Kirin, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Revive Research Institute" are "Crohn Disease" (3 trials), "Covid19" (2 trials), "Crohn's Disease" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Revive Research Institute" in a lesser frequency.

Most popular intervention types in "Revive Research Institute" are "Drug" (21 trials), "Other" (3 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "Binimetinib" (2 trials), "Mirikizumab" (2 trials) and "10 x 10^6 cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Revive Research Institute" are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Revive Research Institute". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Revive Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Revive Research Institute, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".